Presentation TVT 2012 Why Is Frailty Important? Insights from the US CoreValve TAVR Study(2) Presenter: Jeffrey Popma June 05, 2012
Presentation TVT 2012 The Watchman Clinical Studies Program (Warfarin Eligible): Perspectives, New Insights, and Future Directions Presenter: Saibal Kar June 05, 2012
Presentation TVT 2012 Recurrent Mitral Regurgitation (MR) After MV Repair: Incidence and Mechanisms Presenter: Ted Feldman June 05, 2012
Presentation TVT 2012 Targeted Transseptal with TEE: For LAA Occlusion Presenter: 204127|Scott Lim June 05, 2012
Presentation TVT 2012 Frequency and Reasons for Chronic MitraClip Failure After Successful Implantation Presenter: James Hermiller Jr June 05, 2012
Presentation TVT 2012 The Essential Role of CT Planning and TEE Guidance to Optimize Device Deployment Presenter: John Carroll June 05, 2012
Presentation TVT 2012 Is TAVR Being Overused in "Futile" Patients? A Surgeon's Perspective(2) Presenter: Neil Moat June 05, 2012
Presentation TVT 2012 Mitral Valve Surgical Rerepair: Is the Recurrent Failure Rate Even Higher? Presenter: Anelechi Anyanwu June 05, 2012